U.S. District Judge Tanya Walton Pratt issued a temporary restraining order Friday blocking the Indiana Family and Social Services Administration from cutting its Medicaid prescription dispensing fees to $3 from $4.90.
Eli Lilly & Co. CEO John C. Lechleiter said Germany’s overhaul of drug pricing lacked transparency and the new policy creates “uncertainty” for the company’s business planning.
Health care reform will add roughly 500,000 Hoosiers to the Medicaid program and, in spite of great criticism of that expansion, a new study suggests Medicaid coverage does help consumers get more care, have fewer unpaid bills and feel better.
Why do drugmakers still pursue so many me-too drugs? Because, if marketed well, they can be extremely lucrative. Just ask Eli Lilly and Co. about its drug Cialis.
Janssen Pharmaceutica said Thursday it has completed the sale of its animal health business to Eli Lilly and Co. Inc.
Lilly executives are emphatic that they have no plans to reduce the company's 49-cents-a-share quarterly cash dividend, which gives the stock a rich annual yield of 5.2 percent.
Partnership combines wellness, hospital services.
Used parts are in demand as health care reform changes industry dynamic.
Companies that drop insurance coverage could, without spending any more money than they are now, give workers an 11-percent raise or else help them save as much as $2,000 per year buying health coverage in one of the exchanges, IBJ calculations show.
CEO Jim Prieur got more than he bargained for when he took over CNO Financial Group (then-Conseco) five years ago, but he said he’s ready to step down now that the insurer is in good shape.
Bolingbrook, Ill.-based ATI Physical Therapy has acquired Advanced Physical Therapy, which has 175 employees and ranks among the city’s largest operators of physical therapy clinics.
The High Court in London on Tuesday denied Lilly’s request for a judgment without trial against Neopharma Ltd., the closely held company that has European marketing rights for the generic version of the drug known chemically as olanzapine.
Health insurer WellPoint Inc. will pay $100,000 and take other steps after admitting it waited months to notify 32,000 Indiana customers that their Social Security numbers, health records and other personal information might have been exposed online.
A company that reconditions hospital beds plans to expand its operations in southeastern Indiana and potentially add 55 jobs in the next couple of years.
To understand the depths of the pharmaceutical industry’s recent struggles, consider this: The industry has been spending $57 billion more per year on research and development than the value of the products it has been launching. That’s a problem.
Eli Lilly and Co., the Indianapolis-based drugmaker whose best-selling schizophrenia medicine Zyprexa survived a patent challenge in Britain two years ago, has asked a United Kingdom judge to reject a parallel lawsuit by a generic drug company.
Eli Lilly and Co.’s foray into combination drugs is well-timed because the company could take advantage of some the world’s most successful biotech medicines, which are about to see their patents expire.
Marvin Pember, 58, is taking a new job near Philadelphia as the president of the acute care division of Universal Health Services Inc., a publicly traded company with 22 acute hospitals and numerous behavioral health centers spread from coast to coast.
Lilly has 33 drugs in the second and third stages of clinical trials, including medicines for cancer, diabetes and Alzheimer’s disease, up from seven in 2005, the Indianapolis-based company said Thursday.
Indianapolis-based Eli Lilly and Co. raised its spending 8 percent from the $2.3 million that it spent in the first quarter of last year. The drugmaker also spent 70 percent more than the $1.5 million recorded in the final quarter of 2010, according to lobbying reports filed with the House of Representatives.
